152 related articles for article (PubMed ID: 2418482)
1. Recent progress in the immunological monitoring of carcinomas using monoclonal antibodies.
Papsidero LD
Semin Surg Oncol; 1985; 1(4):171-81. PubMed ID: 2418482
[TBL] [Abstract][Full Text] [Related]
2. Binding of five monoclonal anti-CEA antibodies with different epitope specificities to various carcinoma tissues.
Wagener C; Petzold P; Köhler W; Totović V
Int J Cancer; 1984 Apr; 33(4):469-75. PubMed ID: 6200447
[TBL] [Abstract][Full Text] [Related]
3. Clinical experience with the tumor marker Ca 19-9 in an unselected group of more than 300 tumor patients.
Souchon R; Koppenhagen K; Souchon MF; Matthes M; Boese-Landgraf J; Fitzner R; Baer U
Cancer Detect Prev; 1985; 8(1-2):101-9. PubMed ID: 3864534
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies in gastrointestinal cancers.
Mitchell EP; Schlom J
Semin Oncol; 1988 Apr; 15(2):170-80. PubMed ID: 2453081
[TBL] [Abstract][Full Text] [Related]
5. Human tumor-associated antigens identified by monoclonal antibodies.
Hellström KE; Hellström I; Brown JP
Springer Semin Immunopathol; 1982; 5(2):127-46. PubMed ID: 6183764
[No Abstract] [Full Text] [Related]
6. Tumor markers in mammary carcinoma. An evaluation of carcinoembryonic antigen, placental alkaline phosphatase, pseudouridine and CA-50.
Rasmuson T; Björk GR; Damber L; Jacobsson L; Jeppsson A; Stigbrand T; Westman G
Acta Oncol; 1987; 26(4):261-7. PubMed ID: 3479987
[TBL] [Abstract][Full Text] [Related]
7. Use of four monoclonal antibodies to detect tumor markers.
Kawahara M; Terasaki PI; Chia D; Johnson C; Hermes M; Tokita K
Cancer; 1986 Nov; 58(9):2008-12. PubMed ID: 2428463
[TBL] [Abstract][Full Text] [Related]
8. Clinical usefulness of three monoclonal antibody-defined tumor markers: CA 19-9, CA 50, and CA 125.
Szymendera JJ
Tumour Biol; 1986; 7(5-6):333-42. PubMed ID: 2437641
[TBL] [Abstract][Full Text] [Related]
9. Expression of monoclonal antibody-defined tumor markers in four carcinomas.
Wu JT
Ann Clin Lab Sci; 1989; 19(1):17-26. PubMed ID: 2916833
[TBL] [Abstract][Full Text] [Related]
10. [Advantages and limitations of combined assays of 4 serum markers in various types of malignant neoplasms].
Lanza E; Coda C; Ramella S; Ciambellotti E; Moro G; Cartia GL
Minerva Med; 1986 Sep; 77(34-35):1521-5. PubMed ID: 3463886
[TBL] [Abstract][Full Text] [Related]
11. Expression of DR antigens in freshly frozen human tumors.
Thompson JJ; Herlyn MF; Elder DE; Clark WH; Steplewski Z; Koprowski H
Hybridoma; 1982; 1(2):161-8. PubMed ID: 6208123
[TBL] [Abstract][Full Text] [Related]
12. The value of tumor markers in cancer of the ovary.
Cantarow WD; Stolbach LL; Bhattacharya M; Chatterjee SK; Barlow JJ
Int J Radiat Oncol Biol Phys; 1981 Aug; 7(8):1095-8. PubMed ID: 6170620
[No Abstract] [Full Text] [Related]
13. Differential diagnosis between mesotheliomas and metastatic adenocarcinomas using monoclonal antibodies against gastrointestinal carcinoma antigen and stage-specific embryonic antigen.
Ernst CS; Atkinson B; Chianese D; Peters J; Perry M; Herlyn M; Koprowski H
Appl Pathol; 1986; 4(3):115-24. PubMed ID: 2885017
[TBL] [Abstract][Full Text] [Related]
14. [Crucial diagnostic points of tumor markers: gastrointestinal tumors].
Klöppel G
Verh Dtsch Ges Pathol; 1986; 70():159-71. PubMed ID: 2435072
[No Abstract] [Full Text] [Related]
15. The use of tumor markers in the management of patients with gynecologic carcinomas.
Berchuck A; Boente MP; Bast RC
Clin Obstet Gynecol; 1992 Mar; 35(1):45-54. PubMed ID: 1544249
[No Abstract] [Full Text] [Related]
16. Follow-up of metastatic breast cancer patients with a mucin-like carcinoma-associated antigen: comparison to CA 15.3 and carcinoembryonic antigen.
Bieglmayer C; Szepesi T; Neunteufel W
Cancer Lett; 1988 Nov; 42(3):199-206. PubMed ID: 2461250
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of a monoclonal antibody (CA 19-9 system) in gastrointestinal disease--in comparison with CEA and IAP].
Furukawa M; Kozaka S; Kushibiki K; Ashida Y; Saito H; Yamamoto H; Furukawa T
Nihon Gan Chiryo Gakkai Shi; 1985 Feb; 20(1):25-30. PubMed ID: 3858395
[No Abstract] [Full Text] [Related]
18. [Levels of circulating tumor-associated glycoprotein (TAG-72) in patients with carcinoma using a novel tumor marker, CA 72-4].
Ohuchi N; Matoba N; Taira Y; Takahashi K; Sakai N; Sato K; Fujita N; Mochizuki F; Nishihira T; Mori S
Gan To Kagaku Ryoho; 1988 Sep; 15(9):2767-72. PubMed ID: 3166366
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies to human mammary carcinoma associated antigens and their potential uses for diagnosis, prognosis, and therapy.
Colcher D; Hand PH; Wunderlich D; Nuti M; Teramoto YA; Kufe D; Schlom J
Lab Res Methods Biol Med; 1983; 8():215-58. PubMed ID: 6358744
[No Abstract] [Full Text] [Related]
20. Monoclonal antibodies in the diagnosis and treatment of malignant conditions.
Allum WH; Macdonald F; Fielding JW
Surg Annu; 1986; 18():41-64. PubMed ID: 2417343
[No Abstract] [Full Text] [Related]
[Next] [New Search]
